Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma
Authors:
Open Access
- 25 March 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1741513
Abstract
Background: Human leukocyte antigen E (HLA-E) plays a role in tumor immune escape and is associated with poor prognosis in neuroblastoma (NB). This study aimed to investigate the regulatory effect of suberoylanilide hydroxamic acid (SAHA) on HLA-E expression via the PERK/ATF4/CHOP pathway in NB. Methods: A high HLA-E expression model in NB cells was established by stimulation with interferon-gamma (IFN-γ). The effects of SAHA on NB cell proliferation and migration were evaluated. In addition, the influence of SAHA on the PERK/ATF4/CHOP signaling pathway and HLA-E expression at the mRNA and protein levels was analyzed. Bioinformatics analysis was performed using data from the TARGET and Gene Expression Omnibus (GEO; GSE85047) databases to identify prognostic genes associated with NB. Results: Stimulation with IFN-γ successfully induced high HLA-E expression in NB cells. SAHA significantly suppressed NB cell proliferation and migration and downregulated HLA-E expression at both the mRNA and protein levels. Analysis of the TARGET database revealed that the prognosis of patients with NB was closely related to the expression levels of endoplasmic reticulum stress (ERS)-related proteins, particularly PERK and HLA-E. This association was validated using the GEO dataset GSE85047. Moreover, SAHA inhibited the expression of ERS pathway proteins, including PERK and CHOP, in NB cell lines. Conclusion: This study demonstrated that SAHA downregulates HLA-E expression by inhibiting the PERK/ATF4/CHOP pathway, offering new insights into the regulation of tumor proliferation, migration, and immune evasion in NB.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province
This publication has 35 references indexed in Scilit:
- Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaInternational Journal of Cancer, 2022
- The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpressionLaboratory Investigation, 2020
- Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditionsCancer Immunology, Immunotherapy, 2018
- Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myelomaLeukemia, 2015
- Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV‐induced usual vulvar intraepithelial neoplasia and implications for immunotherapyInternational Journal of Cancer, 2014
- Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patientsBritish Journal of Cancer, 2013
- Histone deacetylase inhibitor AR-42 enhances E7-specific CD8+ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccinationJournal of Molecular Medicine, 2013
- Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancerMedical Oncology, 2013
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine DeprivationCancer Cell, 2012
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunitiesNature Reviews Drug Discovery, 2008